{"id":"https://openalex.org/W2052004281","doi":"https://doi.org/10.1158/0008-5472.can-08-2341","title":"Folate Targeting Enables Durable and Specific Antitumor Responses from a Therapeutically Null Tubulysin B Analogue","display_name":"Folate Targeting Enables Durable and Specific Antitumor Responses from a Therapeutically Null Tubulysin B Analogue","publication_year":2008,"publication_date":"2008-12-01","ids":{"openalex":"https://openalex.org/W2052004281","doi":"https://doi.org/10.1158/0008-5472.can-08-2341","mag":"2052004281","pmid":"https://pubmed.ncbi.nlm.nih.gov/19047164"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-08-2341","doi":"https://doi.org/10.1158/0008-5472.can-08-2341","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-08-2341","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/68/23/9839/2591986/9839.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/cancerres/article-pdf/68/23/9839/2591986/9839.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085542989","display_name":"Christopher P. Leamon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher P. Leamon","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, Indiana","institution_ids":["https://openalex.org/I906832008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109996340","display_name":"Joseph A. Reddy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph A. Reddy","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, Indiana","institution_ids":["https://openalex.org/I906832008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043457997","display_name":"Marilynn Vetzel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marilynn Vetzel","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, Indiana","institution_ids":["https://openalex.org/I906832008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002918007","display_name":"Ryan Dorton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Dorton","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, Indiana","institution_ids":["https://openalex.org/I906832008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002632070","display_name":"Elaine M. Westrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elaine Westrick","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, Indiana","institution_ids":["https://openalex.org/I906832008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015130724","display_name":"Nikki L. Parker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikki Parker","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, Indiana","institution_ids":["https://openalex.org/I906832008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100694983","display_name":"Yu Wang","orcid":"https://orcid.org/0000-0003-1251-4159","observed_orcids":["https://orcid.org/0000-0003-1251-4159","https://orcid.org/0000-0001-7285-8004"]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu Wang","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, Indiana","institution_ids":["https://openalex.org/I906832008"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109371739","display_name":"Iontcho R. Vlahov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I906832008","display_name":"Endocyte (United States)","ror":"https://ror.org/058dk4619","country_code":"US","type":"company","lineage":["https://openalex.org/I906832008"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Iontcho Vlahov","raw_affiliation_strings":["Endocyte, Inc., West Lafayette, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocyte, Inc., West Lafayette, Indiana","institution_ids":["https://openalex.org/I906832008"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I906832008"],"apc_list":null,"apc_paid":null,"fwci":4.0781,"has_fulltext":true,"cited_by_count":96,"citation_normalized_percentile":{"value":0.94514113,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"68","issue":"23","first_page":"9839","last_page":"9844"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.4641000032424927,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.4641000032424927,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10499","display_name":"Folate and B Vitamins Research","score":0.2354000061750412,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.054099999368190765,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/folate-receptor","display_name":"folate receptor","score":0.8830000162124634},{"id":"https://openalex.org/keywords/folate-conjugates","display_name":"folate conjugates","score":0.7620000243186951},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.7179999947547913},{"id":"https://openalex.org/keywords/microtubule-inhibitors","display_name":"microtubule inhibitors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8019999861717224},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.4959999918937683},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.3540000021457672}],"concepts":[{"id":"https://openalex.org/C2780306303","wikidata":"https://www.wikidata.org/wiki/Q24784504","display_name":"Folate receptor","level":4,"score":0.7564501762390137},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5960003733634949},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5277500748634338},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4196043014526367},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.4191407859325409},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4086509943008423},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37848982214927673},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37201425433158875},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3308127522468567},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.315473735332489},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.29532697796821594},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23719939589500427},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2368904948234558},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002352","descriptor_name":"Carrier Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005029","descriptor_name":"Ethylenediamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005492","descriptor_name":"Folic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005492","descriptor_name":"Folic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007624","descriptor_name":"KB Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011956","descriptor_name":"Receptors, Cell Surface","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013379","descriptor_name":"Substrate Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D019793","descriptor_name":"Fluorescein","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058973","descriptor_name":"Folate Receptors, GPI-Anchored","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.can-08-2341","doi":"https://doi.org/10.1158/0008-5472.can-08-2341","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-08-2341","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/68/23/9839/2591986/9839.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:19047164","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19047164","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.can-08-2341","doi":"https://doi.org/10.1158/0008-5472.can-08-2341","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-08-2341","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/68/23/9839/2591986/9839.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309036","display_name":"Purdue University","ror":"https://ror.org/02dqehb95"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2052004281.pdf","grobid_xml":"https://content.openalex.org/works/W2052004281.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1492263135","https://openalex.org/W1560482245","https://openalex.org/W1853165005","https://openalex.org/W1965931924","https://openalex.org/W1969855337","https://openalex.org/W1971341208","https://openalex.org/W1972833865","https://openalex.org/W1975556125","https://openalex.org/W1982985645","https://openalex.org/W2009885156","https://openalex.org/W2013919931","https://openalex.org/W2023298707","https://openalex.org/W2033463544","https://openalex.org/W2042493999","https://openalex.org/W2042885996","https://openalex.org/W2055954943","https://openalex.org/W2059965787","https://openalex.org/W2060459188","https://openalex.org/W2075136037","https://openalex.org/W2084357980","https://openalex.org/W2085690616","https://openalex.org/W2090540963","https://openalex.org/W2100398499","https://openalex.org/W2105678378","https://openalex.org/W2114230622","https://openalex.org/W2120919288","https://openalex.org/W2121184374","https://openalex.org/W2127168225","https://openalex.org/W2137231887","https://openalex.org/W2140853963","https://openalex.org/W2254792577","https://openalex.org/W2342756497","https://openalex.org/W2413966932","https://openalex.org/W2485063231","https://openalex.org/W2500891140","https://openalex.org/W4232914070"],"related_works":["https://openalex.org/W2048945971","https://openalex.org/W2077908737","https://openalex.org/W2734620733","https://openalex.org/W1506446568","https://openalex.org/W2609784207","https://openalex.org/W2806683929","https://openalex.org/W3159427981","https://openalex.org/W2055954943","https://openalex.org/W2090540963","https://openalex.org/W2127168225"],"abstract_inverted_index":{"The":[0,115,190],"membrane-bound":[1],"high-affinity":[2],"folate":[3,56,79,194],"receptor":[4],"(FR)":[5],"is":[6],"highly":[7,215],"expressed":[8],"on":[9],"a":[10,60,77,94,105,123,131,173],"wide":[11],"range":[12],"of":[13,45,53,64,93,96,117,172,183],"primary":[14],"and":[15,29,36,214],"metastatic":[16],"human":[17,124],"cancers,":[18],"such":[19],"as":[20,84],"those":[21],"originating":[22],"in":[23,75,104,163],"ovary,":[24],"lung,":[25],"breast,":[26],"endometrium,":[27],"kidney,":[28],"brain.":[30],"Because":[31],"folate-linked":[32],"conjugates":[33],"bind":[34],"to":[35,43,58,70,83,88,207,233,236],"become":[37],"internalized":[38],"within":[39],"FR-expressing":[40],"cells":[41,109],"(similar":[42],"that":[44,166,179,223],"free":[46,202],"folic":[47],"acid),":[48],"we":[49],"explored":[50],"the":[51,55,65,91,180,200],"possibility":[52],"using":[54,241],"ligand":[57],"target":[59],"potent,":[61],"semisynthetic":[62],"analogue":[63],"microtubule":[66],"inhibitor":[67],"tubulysin":[68,227],"B":[69],"FR-enriched":[71],"tumors.":[72],"When":[73],"tested":[74],"vitro,":[76],"novel":[78],"conjugate,":[80],"herein":[81],"referred":[82],"EC0305,":[85],"was":[86,119,160,186,196,205],"found":[87,206],"specifically":[89,231],"inhibit":[90],"growth":[92],"panel":[95],"FR-positive":[97,234],"cell":[98],"lines":[99],"(IC50":[100],"range,":[101],"1-10":[102],"nmol/L)":[103],"dose-dependent":[106],"manner,":[107],"whereas":[108],"lacking":[110],"FR":[111],"expression":[112],"were":[113,167],"unaffected.":[114],"potency":[116],"EC0305":[118],"also":[120],"confirmed":[121],"against":[122],"KB":[125],"xenograft-nu/nu":[126],"mouse":[127],"cancer":[128],"model.":[129],"Here,":[130],"brief":[132],"three":[133],"times":[134],"per":[135],"week,":[136],"2-week":[137],"regimen":[138],"yielded":[139],"remarkable":[140],"antitumor":[141,158,181],"activity":[142,159],"(100%":[143],"tumor-free":[144],"animals)":[145],"without":[146],"causing":[147],"significant":[148],"weight":[149],"loss":[150],"or":[151],"major":[152],"organ":[153],"tissue":[154],"degeneration.":[155],"In":[156],"contrast,":[157],"completely":[161,209],"abolished":[162],"EC0305-treated":[164],"animals":[165],"co-dosed":[168],"with":[169],"an":[170],"excess":[171],"nontoxic":[174],"folate-containing":[175],"analogue,":[176],"thereby":[177],"confirming":[178],"effect":[182],"this":[184,224],"agent":[185],"mediated":[187],"by":[188,193,199],"FRs.":[189],"advantage":[191],"provided":[192],"conjugation":[195],"further":[197],"proved":[198],"untargeted":[201],"drug,":[203],"which":[204],"be":[208,230],"inactive":[210],"at":[211],"both":[212],"tolerable":[213],"toxic":[216],"dose":[217],"levels.":[218],"Collectively,":[219],"these":[220],"results":[221],"show":[222],"potent":[225],"antiproliferative":[226],"compound":[228],"can":[229],"delivered":[232],"tumors":[235],"provide":[237],"substantial":[238],"therapeutic":[239],"benefit":[240],"well-tolerable":[242],"dosing":[243],"regimens.":[244]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}